{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:21Z","timestamp":1792783401566,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Thea Pharma Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40123-025-01161-8","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T01:02:30Z","timestamp":1748394150000},"page":"1411-1428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Dry Eye Disease: From Causes to Patient Care and Clinical Collaboration\u2014A Narrative Review"],"prefix":"10.1007","volume":"14","author":[{"given":"Pasquale","family":"Aragona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-5973","authenticated-orcid":false,"given":"Antonio","family":"Di Zazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Antoniazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cantera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Chierego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Colabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Fasciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Franch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gabbriellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Maria Rita","family":"Gagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-8580","authenticated-orcid":false,"given":"Andrea","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Mencucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Orfeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Pocobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romolo","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rechichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangela","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Scorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Trentadue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Versura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rolando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"3","key":"1161_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/J.JTOS.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.003.","journal-title":"Ocul Surf"},{"issue":"2","key":"1161_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","volume":"36","author":"PA Rouen","year":"2018","unstructured":"Rouen PA, White ML. Dry eye disease: prevalence, assessment, and management. Home Healthc Now. 2018;36(2):74\u201383. https:\/\/doi.org\/10.1097\/NHH.0000000000000652.","journal-title":"Home Healthc Now"},{"key":"1161_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-82753-9.00013-8","author":"J Kalangara","year":"2023","unstructured":"Kalangara J, Kuruvilla M, Sarantopoulos KD. Treatment of ocular pain not responsive to traditional dry eye disease treatments. Dry Eye Dis. 2023. https:\/\/doi.org\/10.1016\/B978-0-323-82753-9.00013-8.","journal-title":"Dry Eye Dis"},{"key":"1161_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120960586","volume-title":"Updated definition and classification of dry eye disease: renewed proposals using the nominal group and Delphi techniques","author":"S Barabino","year":"2021","unstructured":"Barabino S, et al. Updated definition and classification of dry eye disease: renewed proposals using the nominal group and Delphi techniques. London: SAGE Publications; 2021. https:\/\/doi.org\/10.1177\/1120672120960586."},{"issue":"3","key":"1161_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/09273948.2019.1682618","volume":"29","author":"M Rolando","year":"2021","unstructured":"Rolando M, Zierhut M, Barabino S. Should we reconsider the classification of patients with dry eye disease? Ocul Immunol Inflamm. 2021;29(3):521\u20133. https:\/\/doi.org\/10.1080\/09273948.2019.1682618.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"1161_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/BJOPHTHALMOL-2019-315747","volume":"105","author":"P Aragona","year":"2021","unstructured":"Aragona P, Giannaccare G, Mencucci R, Rubino P, Cantera E, Rolando M. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review. Br J Ophthalmol. 2021;105(4):446\u201353. https:\/\/doi.org\/10.1136\/BJOPHTHALMOL-2019-315747.","journal-title":"Br J Ophthalmol"},{"issue":"21","key":"1161_CR7","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.3390\/JCM11216437","volume":"11","author":"P Aragona","year":"2022","unstructured":"Aragona P, et al. The management of dry eye disease: Proceedings of Italian dry eye consensus group using the Delphi method. J Clin Med. 2022;11(21):6437. https:\/\/doi.org\/10.3390\/JCM11216437.","journal-title":"J Clin Med"},{"issue":"3","key":"1161_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/J.JTOS.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.008.","journal-title":"Ocul Surf"},{"issue":"3","key":"1161_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/J.JTOS.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438\u2013510. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.011.","journal-title":"Ocul Surf"},{"key":"1161_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/JCM12062205","author":"M Rolando","year":"2023","unstructured":"Rolando M, Barabino S, Giannaccare G, Aragona P. Dealing with the persistent pathogenic issues of dry eye disease: the importance of external and internal stimuli and tissue responses. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/JCM12062205.","journal-title":"J Clin Med"},{"key":"1161_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS12232755","author":"CR Harrell","year":"2023","unstructured":"Harrell CR, Feulner L, Djonov V, Pavlovic D, Volarevic V. The molecular mechanisms responsible for tear hyperosmolarity-induced pathological changes in the eyes of dry eye disease patients. Cells. 2023. https:\/\/doi.org\/10.3390\/CELLS12232755.","journal-title":"Cells"},{"issue":"3","key":"1161_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/S40123-023-00669-1","volume":"12","author":"JD Sheppard","year":"2023","unstructured":"Sheppard JD, Nichols KK. Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape. Ophthalmol Ther. 2023;12(3):1397. https:\/\/doi.org\/10.1007\/S40123-023-00669-1.","journal-title":"Ophthalmol Ther"},{"key":"1161_CR13","doi-asserted-by":"publisher","first-page":"1307682","DOI":"10.3389\/FMED.2024.1307682\/BIBTEX","volume":"11","author":"L Chu","year":"2024","unstructured":"Chu L, Wang C, Zhou H. Inflammation mechanism and anti-inflammatory therapy of dry eye. Front Med (Lausanne). 2024;11:1307682. https:\/\/doi.org\/10.3389\/FMED.2024.1307682\/BIBTEX.","journal-title":"Front Med (Lausanne)"},{"key":"1161_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/J.NPEP.2022.102266","author":"K Asiedu","year":"2022","unstructured":"Asiedu K. Role of ocular surface neurobiology in neuronal-mediated inflammation in dry eye disease. Neuropeptides. 2022. https:\/\/doi.org\/10.1016\/J.NPEP.2022.102266.","journal-title":"Neuropeptides"},{"issue":"4","key":"1161_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/J.JTOS.2013.07.003","volume":"11","author":"C Baudouin","year":"2013","unstructured":"Baudouin C, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11(4):246\u201358. https:\/\/doi.org\/10.1016\/J.JTOS.2013.07.003.","journal-title":"Ocul Surf"},{"issue":"4","key":"1161_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/09273948.2021.1906908","volume":"29","author":"M Rolando","year":"2021","unstructured":"Rolando M, Barabino S. The subtle role of para-inflammation in modulating the progression of dry eye disease. Ocul Immunol Inflamm. 2021;29(4):811\u20136. https:\/\/doi.org\/10.1080\/09273948.2021.1906908.","journal-title":"Ocul Immunol Inflamm"},{"key":"1161_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/285851","author":"FT Fraunfelder","year":"2012","unstructured":"Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medications in causing dry eye. J Ophthalmol. 2012. https:\/\/doi.org\/10.1155\/2012\/285851.","journal-title":"J Ophthalmol"},{"issue":"3","key":"1161_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/J.JTOS.2017.05.004","volume":"15","author":"JAP Gomes","year":"2017","unstructured":"Gomes JAP, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511\u201338. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.004.","journal-title":"Ocul Surf"},{"key":"1161_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/JCM13030748","author":"G Giannaccare","year":"2024","unstructured":"Giannaccare G, Barabino S, Di Zazzo A, Villani E. Preventing and managing iatrogenic dry eye disease during the entire surgical pathway: a study focusing on patients undergoing cataract surgery. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/JCM13030748.","journal-title":"J Clin Med"},{"key":"1161_CR20","doi-asserted-by":"publisher","unstructured":"E. M. Messmer, \u201cThe pathophysiology, diagnosis, and treatment of dry eye disease,\u201d Dtsch Arztebl Int, vol. 112, no. 5, Jan. 2015, https:\/\/doi.org\/10.3238\/ARZTEBL.2015.0071.","DOI":"10.3238\/ARZTEBL.2015.0071"},{"issue":"2","key":"1161_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/S10792-017-0524-4","volume":"38","author":"M Rolando","year":"2018","unstructured":"Rolando M, Cantera E, Mencucci R, Rubino P, Aragona P. The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board. Int Ophthalmol. 2018;38(2):875\u201395. https:\/\/doi.org\/10.1007\/S10792-017-0524-4.","journal-title":"Int Ophthalmol"},{"key":"1161_CR22","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2147\/OPTH.S89700","volume":"9","author":"JD Bartlett","year":"2015","unstructured":"Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol. 2015;9:1719. https:\/\/doi.org\/10.2147\/OPTH.S89700.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1161_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/J.OPTOM.2020.10.002","volume":"14","author":"CW McMonnies","year":"2021","unstructured":"McMonnies CW. Why the symptoms and objective signs of dry eye disease may not correlate. J Optom. 2021;14(1):3\u201310. https:\/\/doi.org\/10.1016\/J.OPTOM.2020.10.002.","journal-title":"J Optom"},{"issue":"1","key":"1161_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1542-0124(12)70290-2","volume":"7","author":"P Rosenthal","year":"2009","unstructured":"Rosenthal P, Baran I, Jacobs DS. Corneal pain without stain: is it real? Ocul Surf. 2009;7(1):28\u201340. https:\/\/doi.org\/10.1016\/S1542-0124(12)70290-2.","journal-title":"Ocul Surf"},{"issue":"4","key":"1161_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/17469899.2023.2258285","volume":"18","author":"JV Aquavella","year":"2023","unstructured":"Aquavella JV, Santiago E, Zavislan JM. Advances in dry eye. Expert Rev Ophthalmol. 2023;18(4):231\u20134. https:\/\/doi.org\/10.1080\/17469899.2023.2258285.","journal-title":"Expert Rev Ophthalmol"},{"key":"1161_CR26","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/OPTH.S388289","volume":"17","author":"T Chester","year":"2023","unstructured":"Chester T, Garg SS, Johnston J, Ayers B, Gupta P. How can we best diagnose severity levels of dry eye disease: current perspectives. Clin Ophthalmol. 2023;17:1587. https:\/\/doi.org\/10.2147\/OPTH.S388289.","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"1161_CR27","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/S40123-024-01034-6","volume":"13","author":"P Fogagnolo","year":"2024","unstructured":"Fogagnolo P, et al. High-tech parameters for the evaluation of signs and symptoms of dry eye disease: identification of clinical cut-offs and agreement with low-tech tests. Ophthalmol Ther. 2024;13(11):2999. https:\/\/doi.org\/10.1007\/S40123-024-01034-6.","journal-title":"Ophthalmol Ther"},{"key":"1161_CR28","doi-asserted-by":"publisher","first-page":"826530","DOI":"10.3389\/FMED.2021.826530","volume":"8","author":"Y Wu","year":"2022","unstructured":"Wu Y, et al. Advances in dry eye disease examination techniques. Front Med (Lausanne). 2022;8:826530. https:\/\/doi.org\/10.3389\/FMED.2021.826530.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1161_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.17925\/EOR.2019.13.1.21","volume":"13","author":"A Chiva","year":"2019","unstructured":"Chiva A. Tear biomarkers in dry eye disease. Eur Ophthalmic Rev. 2019;13(1):21. https:\/\/doi.org\/10.17925\/EOR.2019.13.1.21.","journal-title":"Eur Ophthalmic Rev"},{"issue":"3","key":"1161_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/J.JTOS.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u201374. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.001.","journal-title":"Ocul Surf"},{"key":"1161_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/JCM13030710","author":"A Di Zazzo","year":"2024","unstructured":"Di Zazzo A, Giannaccare G, Villani E, Barabino S. Uncommon blepharitis. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/JCM13030710.","journal-title":"J Clin Med"},{"issue":"2","key":"1161_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"MA Lemp","year":"2007","unstructured":"Lemp MA, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75\u201392. https:\/\/doi.org\/10.1016\/S1542-0124(12)70081-2.","journal-title":"Ocul Surf"},{"issue":"9","key":"1161_CR33","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/BJOPHTHALMOL-2013-304619","volume":"98","author":"C Baudouin","year":"2014","unstructured":"Baudouin C, et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168\u201376. https:\/\/doi.org\/10.1136\/BJOPHTHALMOL-2013-304619.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1161_CR34","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3390\/JCM11092507","volume":"11","author":"P Aragona","year":"2022","unstructured":"Aragona P, Giannaccare G, Rolando M. Special issue \u2018Managing dry eye disease over time: an Italian consensus conference.\u2019 J Clin Med. 2022;11(9):2507. https:\/\/doi.org\/10.3390\/JCM11092507.","journal-title":"J Clin Med"},{"issue":"5","key":"1161_CR35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/JCM13051220","volume":"13","author":"A Di Zazzo","year":"2024","unstructured":"Di Zazzo A, et al. One soul and several faces of evaporative dry eye disease. J Clin Med. 2024;13(5):1220. https:\/\/doi.org\/10.3390\/JCM13051220.","journal-title":"J Clin Med"},{"issue":"12","key":"1161_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/DIAGNOSTICS14121209","volume":"14","author":"S Vaccaro","year":"2024","unstructured":"Vaccaro S, et al. A novel noninvasive screening tool for dry eye disease. Diagnostics. 2024;14(12):1209. https:\/\/doi.org\/10.3390\/DIAGNOSTICS14121209.","journal-title":"Diagnostics"},{"issue":"22","key":"1161_CR37","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.3390\/JCM13226927","volume":"13","author":"A Di Zazzo","year":"2024","unstructured":"Di Zazzo A, Villani E, Barabino S, Giannaccare G. How eyelid changes may impact on tears. J Clin Med. 2024;13(22):6927. https:\/\/doi.org\/10.3390\/JCM13226927.","journal-title":"J Clin Med"},{"issue":"3","key":"1161_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/J.JTOS.2016.04.005","volume":"14","author":"S Barabino","year":"2016","unstructured":"Barabino S, Labetoulle M, Rolando M, Messmer EM. Understanding symptoms and quality of life in patients with dry eye syndrome. Ocul Surf. 2016;14(3):365\u201376. https:\/\/doi.org\/10.1016\/J.JTOS.2016.04.005.","journal-title":"Ocul Surf"},{"key":"1161_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.JTOS.2021.05.006","volume":"21","author":"MK Morthen","year":"2021","unstructured":"Morthen MK, Magno MS, Utheim TP, Snieder H, Hammond CJ, Vehof J. The physical and mental burden of dry eye disease: a large population-based study investigating the relationship with health-related quality of life and its determinants. Ocul Surf. 2021;21:107\u201317. https:\/\/doi.org\/10.1016\/J.JTOS.2021.05.006.","journal-title":"Ocul Surf"},{"issue":"6","key":"1161_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/S40271-022-00586-8\/FIGURES\/3","volume":"15","author":"S Ozdemir","year":"2022","unstructured":"Ozdemir S, Yeo SWJ, Lee JJ, Bhaskar A, Finkelstein E, Tong L. Patient medication preferences for managing dry eye disease: the importance of medication side effects. Patient. 2022;15(6):679\u201390. https:\/\/doi.org\/10.1007\/S40271-022-00586-8\/FIGURES\/3.","journal-title":"Patient"},{"issue":"3","key":"1161_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/J.JTOS.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.006.","journal-title":"Ocul Surf"},{"key":"1161_CR42","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/OPTH.S211611","volume":"13","author":"K Walsh","year":"2019","unstructured":"Walsh K, Jones L. The use of preservatives in dry eye drops. Clin Ophthalmol. 2019;13:1409. https:\/\/doi.org\/10.2147\/OPTH.S211611.","journal-title":"Clin Ophthalmol"},{"key":"1161_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/J.JFO.2024.104169","author":"L El Fekih","year":"2024","unstructured":"El Fekih L, Khairallah M, BenAmor H, Mahmoud A, Chiambaretta F, Messaoud R. Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA). J Fr Ophtalmol. 2024. https:\/\/doi.org\/10.1016\/J.JFO.2024.104169.","journal-title":"J Fr Ophtalmol"},{"issue":"4","key":"1161_CR44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2450\/2020.0130-20","volume":"19","author":"D Samarkanova","year":"2021","unstructured":"Samarkanova D, et al. Clinical evaluation of allogeneic eye drops from cord blood platelet lysate. Blood Transfus. 2021;19(4):347\u201356. https:\/\/doi.org\/10.2450\/2020.0130-20.","journal-title":"Blood Transfus"},{"issue":"9","key":"1161_CR45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/ICO.0000000000002943","volume":"41","author":"P Jongkhajornpong","year":"2022","unstructured":"Jongkhajornpong P, et al. Short-term efficacy and safety of biological tear substitutes and topical secretagogues for dry eye disease: a systematic review and network meta-analysis. Cornea. 2022;41(9):1137\u201349. https:\/\/doi.org\/10.1097\/ICO.0000000000002943.","journal-title":"Cornea"},{"key":"1161_CR46","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.2147\/OPTH.S384819","volume":"16","author":"C Matossian","year":"2022","unstructured":"Matossian C, Crowley M, Periman L, Sorkin S. Personalized management of dry eye disease: beyond artificial tears. Clin Ophthalmol. 2022;16:3911\u20138. https:\/\/doi.org\/10.2147\/OPTH.S384819.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1161_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/J.JTOS.2015.11.002","volume":"14","author":"M McDonald","year":"2016","unstructured":"McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocul Surf. 2016;14(2):144\u201367. https:\/\/doi.org\/10.1016\/J.JTOS.2015.11.002.","journal-title":"Ocul Surf"},{"key":"1161_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0999-3","author":"C Shigeyasu","year":"2018","unstructured":"Shigeyasu C, Yamada M, Kawashima M, Suwaki K, Uchino M, Hiratsuka Y, Yokoi N, et al. Quality of life measures and health utility values among dry eye subgroups. Health Qual Life Outcomes. 2018. https:\/\/doi.org\/10.1186\/s12955-018-0999-3.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"1161_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/TVST.7.6.35","volume":"7","author":"M Kitazawa","year":"2018","unstructured":"Kitazawa M, et al. The relationship of dry eye disease with depression and anxiety: a naturalistic observational study. Transl Vis Sci Technol. 2018;7(6):35\u201335. https:\/\/doi.org\/10.1167\/TVST.7.6.35.","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"1161_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/JCM14010196","volume":"14","author":"E Villani","year":"2025","unstructured":"Villani E, Barabino S, Giannaccare G, Di Zazzo A, Aragona P, Rolando M. From symptoms to satisfaction: optimizing patient-centered care in dry eye disease. J Clin Med. 2025;14(1):196. https:\/\/doi.org\/10.3390\/JCM14010196.","journal-title":"J Clin Med"},{"issue":"4","key":"1161_CR51","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/S40123-020-00308-Z","volume":"9","author":"MA Verjee","year":"2020","unstructured":"Verjee MA, Brissette AR, Starr CE. Dry Eye disease: early recognition with guidance on management and treatment for primary care family physicians. Ophthalmol Ther. 2020;9(4):877\u201388. https:\/\/doi.org\/10.1007\/S40123-020-00308-Z.","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"1161_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1089\/JWH.2018.7041","volume":"28","author":"C Matossian","year":"2019","unstructured":"Matossian C, McDonald M, Donaldson KE, Nichols KK, Maciver S, Gupta PK. Dry eye disease: consideration for women\u2019s health. J Womens Health. 2019;28(4):502. https:\/\/doi.org\/10.1089\/JWH.2018.7041.","journal-title":"J Womens Health"},{"issue":"3","key":"1161_CR53","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/S41433-021-01517-X","volume":"36","author":"B He","year":"2022","unstructured":"He B, Iovieno A, Etminan M, Kezouh A, Yeung SN. Effects of hormonal contraceptives on dry eye disease: a population-based study. Eye (London). 2022;36(3):634\u20138. https:\/\/doi.org\/10.1038\/S41433-021-01517-X.","journal-title":"Eye (London)"},{"issue":"1","key":"1161_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/J.OPTOM.2012.08.006","volume":"6","author":"F Kemdinum Idu","year":"2013","unstructured":"Kemdinum Idu F, Osita Emina M, Oyem Ubaru C. Tear secretion and tear stability of women on hormonal contraceptives. J Optom. 2013;6(1):45. https:\/\/doi.org\/10.1016\/J.OPTOM.2012.08.006.","journal-title":"J Optom"},{"issue":"17","key":"1161_CR55","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/JAMA.286.17.2114","volume":"286","author":"DA Schaumberg","year":"2001","unstructured":"Schaumberg DA, Buring JE, Sullivan DA, RezaDana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286(17):2114\u20139. https:\/\/doi.org\/10.1001\/JAMA.286.17.2114.","journal-title":"JAMA"},{"issue":"5","key":"1161_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/J.AJO.2007.01.030","volume":"143","author":"S Bonini","year":"2007","unstructured":"Bonini S, Mantelli F, Moretti C, Lambiase A, Bonini S, Micera A. Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol. 2007;143(5):763-771.e2. https:\/\/doi.org\/10.1016\/J.AJO.2007.01.030.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1161_CR57","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4103\/IJO.IJO_2887_22","volume":"71","author":"B Gorimanipalli","year":"2023","unstructured":"Gorimanipalli B, Khamar P, Sethu S, Shetty R. Hormones and dry eye disease. Indian J Ophthalmol. 2023;71(4):1276\u201384. https:\/\/doi.org\/10.4103\/IJO.IJO_2887_22.","journal-title":"Indian J Ophthalmol"},{"key":"1161_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/J.SURVOPHTHAL.2025.03.001","author":"A Rodriguez-Garcia","year":"2025","unstructured":"Rodriguez-Garcia A, Ruiz-Lozano RE, Barcelo-Canton RH, Marines-Sanchez HM, Homar Paez-Garza J. The etiologic and pathogenic spectrum of exposure keratopathy: diagnostic and therapeutic implications. Surv Ophthalmol. 2025. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2025.03.001.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"1161_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMOA1910434\/SUPPL_FILE\/NEJMOA1910434_DATA-SHARING.PDF","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, et al. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med. 2020;382(4):341\u201352. https:\/\/doi.org\/10.1056\/NEJMOA1910434\/SUPPL_FILE\/NEJMOA1910434_DATA-SHARING.PDF.","journal-title":"N Engl J Med"},{"issue":"18","key":"1161_CR60","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMOA1614949\/SUPPL_FILE\/NEJMOA1614949_DISCLOSURES.PDF","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, et al. Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med. 2017;376(18):1748\u201361. https:\/\/doi.org\/10.1056\/NEJMOA1614949\/SUPPL_FILE\/NEJMOA1614949_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"issue":"1","key":"1161_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/J.PCD.2020.01.011","volume":"15","author":"GR De Freitas","year":"2021","unstructured":"De Freitas GR, Ferraz GAM, Gehlen M, Skare TL. Dry eyes in patients with diabetes mellitus. Prim Care Diabetes. 2021;15(1):184\u20136. https:\/\/doi.org\/10.1016\/J.PCD.2020.01.011.","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"1161_CR62","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/BIOM13050724","volume":"13","author":"H Shan","year":"2023","unstructured":"Shan H, Liu W, Li Y, Pang K. The autoimmune rheumatic disease related dry eye and its association with retinopathy. Biomolecules. 2023;13(5):724. https:\/\/doi.org\/10.3390\/BIOM13050724.","journal-title":"Biomolecules"},{"issue":"1","key":"1161_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.IMLET.2011.06.007","volume":"141","author":"R Jonsson","year":"2011","unstructured":"Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sj\u00f6gren\u2019s syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141(1):1\u20139. https:\/\/doi.org\/10.1016\/J.IMLET.2011.06.007.","journal-title":"Immunol Lett"},{"issue":"2","key":"1161_CR64","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/S10792-019-01183-9\/FIGURES\/3","volume":"40","author":"A Kemeny-Beke","year":"2020","unstructured":"Kemeny-Beke A, Szodoray P. Ocular manifestations of rheumatic diseases. Int Ophthalmol. 2020;40(2):503\u201310. https:\/\/doi.org\/10.1007\/S10792-019-01183-9\/FIGURES\/3.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"1161_CR65","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/S00296-011-2296-X","volume":"33","author":"RR El-Shereef","year":"2013","unstructured":"El-Shereef RR, Mohamed AS, Hamdy L. Ocular manifestation of systemic lupus erythematosus. Rheumatol Int. 2013;33(6):1637\u201342. https:\/\/doi.org\/10.1007\/S00296-011-2296-X.","journal-title":"Rheumatol Int"},{"issue":"3","key":"1161_CR66","doi-asserted-by":"publisher","first-page":"127","DOI":"10.31138\/MJR.29.3.127","volume":"29","author":"S Ziaragkali","year":"2018","unstructured":"Ziaragkali S, Kotsalidou A, Trakos N. Dry eye disease in routine rheumatology practice. Mediterr J Rheumatol. 2018;29(3):127. https:\/\/doi.org\/10.31138\/MJR.29.3.127.","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"1161_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157339711794474602","volume":"7","author":"S Taylor","year":"2011","unstructured":"Taylor S, Pacheco P, Lightman S. Dry eyes in rheumatic disease. Curr Rheumatol Rev. 2011;7(1):3\u201314. https:\/\/doi.org\/10.2174\/157339711794474602.","journal-title":"Curr Rheumatol Rev"},{"key":"1161_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/J.PRETEYERES.2024.101250","author":"M Labetoulle","year":"2024","unstructured":"Labetoulle M, et al. How gut microbiota may impact ocular surface homeostasis and related disorders. Prog Retin Eye Res. 2024. https:\/\/doi.org\/10.1016\/J.PRETEYERES.2024.101250.","journal-title":"Prog Retin Eye Res"},{"key":"1161_CR69","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/J.JTOS.2023.04.003","volume":"29","author":"M Markoulli","year":"2023","unstructured":"Markoulli M, et al. TFOS lifestyle: impact of nutrition on the ocular surface. Ocul Surf. 2023;29:226\u201371. https:\/\/doi.org\/10.1016\/J.JTOS.2023.04.003.","journal-title":"Ocul Surf"},{"key":"1161_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.874021","author":"L Yang","year":"2022","unstructured":"Yang L, Xiang Z, Zou J, Zhang Y, Ni Y, Yang J. Comprehensive analysis of the relationships between the gut microbiota and fecal metabolome in individuals with primary Sjogren\u2019s syndrome by 16S rRNA sequencing and LC\u2013MS-based metabolomics. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/FIMMU.2022.874021.","journal-title":"Front Immunol"},{"key":"1161_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/S12934-020-01348-7","author":"R Mendez","year":"2020","unstructured":"Mendez R, et al. Gut microbial dysbiosis in individuals with Sj\u00f6gren\u2019s syndrome. Microb Cell Fact. 2020. https:\/\/doi.org\/10.1186\/S12934-020-01348-7.","journal-title":"Microb Cell Fact"},{"issue":"4","key":"1161_CR72","doi-asserted-by":"publisher","first-page":"487","DOI":"10.20524\/AOG.2016.0064","volume":"29","author":"I Asproudis","year":"2016","unstructured":"Asproudis I, et al. Irritable bowel syndrome might be associated with dry eye disease. Ann Gastroenterol Q Publ Hellenic Soc Gastroenterol. 2016;29(4):487. https:\/\/doi.org\/10.20524\/AOG.2016.0064.","journal-title":"Ann Gastroenterol Q Publ Hellenic Soc Gastroenterol"},{"issue":"1","key":"1161_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/S12886-023-03165-Z","volume":"23","author":"YT Ko","year":"2023","unstructured":"Ko YT, et al. Inflammatory bowel disease and the associated risk of dry eye and ocular surface injury: a nationwide matched cohort study. BMC Ophthalmol. 2023;23(1):415. https:\/\/doi.org\/10.1186\/S12886-023-03165-Z.","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"1161_CR74","first-page":"4442","volume":"56","author":"I Petricek","year":"2015","unstructured":"Petricek I, Tomic M. Dry eye and dry skin\u2014is there a connection? Investig Ophthalmol Vis Sci. 2015;56(7):4442\u20134442.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"1161_CR75","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1159\/000522167","volume":"238","author":"PC Wu","year":"2022","unstructured":"Wu PC, Ma SH, Huang YY, Chang JY, Chang YT, Dai YX. Psoriasis and dry eye disease: a systematic review and meta-analysis. Dermatology. 2022;238(5):876\u201385. https:\/\/doi.org\/10.1159\/000522167.","journal-title":"Dermatology"},{"issue":"3","key":"1161_CR76","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/09273948.2021.2025251","volume":"30","author":"B Sobolewska","year":"2022","unstructured":"Sobolewska B, Schaller M, Zierhut M. Rosacea and dry eye disease. Ocul Immunol Inflamm. 2022;30(3):570\u20139. https:\/\/doi.org\/10.1080\/09273948.2021.2025251.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"1161_CR77","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/ICO.0000000000000393","volume":"34","author":"M Palamar","year":"2015","unstructured":"Palamar M, Degirmenci C, Ertam I, Yagci A. Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea. Cornea. 2015;34(5):497\u20139. https:\/\/doi.org\/10.1097\/ICO.0000000000000393.","journal-title":"Cornea"},{"issue":"2","key":"1161_CR78","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/J.SURVOPHTHAL.2023.10.002","volume":"69","author":"R Boucher","year":"2024","unstructured":"Boucher R, et al. Ocular surface toxicities associated with modern anticancer therapies. Surv Ophthalmol. 2024;69(2):198\u2013210. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2023.10.002.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"1161_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/08164622.2023.2239247","volume":"107","author":"G Machairoudia","year":"2024","unstructured":"Machairoudia G, et al. Prevalence and risk factors of dry eye disease in patients treated with aromatase inhibitors for breast cancer. Clin Exp Optom. 2024;107(4):415\u20139. https:\/\/doi.org\/10.1080\/08164622.2023.2239247.","journal-title":"Clin Exp Optom"},{"issue":"1","key":"1161_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-81398-y","volume":"11","author":"JCB Chiang","year":"2021","unstructured":"Chiang JCB, et al. A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer. Sci Rep. 2021;11(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-021-81398-y.","journal-title":"Sci Rep"},{"issue":"4","key":"1161_CR81","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.4103\/IJO.IJO_2673_22","volume":"71","author":"M Soni","year":"2023","unstructured":"Soni M, Walia S, Jain P. Dry eye disease in head and neck cancer patients undergoing radiotherapy. Indian J Ophthalmol. 2023;71(4):1556. https:\/\/doi.org\/10.4103\/IJO.IJO_2673_22.","journal-title":"Indian J Ophthalmol"},{"key":"1161_CR82","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.2147\/OPTH.S263291","volume":"14","author":"R Nuzzi","year":"2020","unstructured":"Nuzzi R, et al. Ocular complications after radiation therapy: an observational study. Clin Ophthalmol. 2020;14:3153\u201366. https:\/\/doi.org\/10.2147\/OPTH.S263291.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1161_CR83","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/LIFE14040530","volume":"14","author":"CY Lee","year":"2024","unstructured":"Lee CY, Yang SF, Chang YL, Huang JY, Chang CK. The association between ovarian cancer and the incidence of newly developed dry eye disease: a nationwide population-based study. Life. 2024;14(4):530. https:\/\/doi.org\/10.3390\/LIFE14040530.","journal-title":"Life"},{"key":"1161_CR84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/EB.S117261","volume":"10","author":"P Versura","year":"2018","unstructured":"Versura P, Giannaccare G, Pellegrini M, Sebastiani S, Campos EC. Neurotrophic keratitis: current challenges and future prospects. Eye Brain. 2018;10:37\u201345. https:\/\/doi.org\/10.2147\/EB.S117261.","journal-title":"Eye Brain"},{"key":"1161_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/848659","author":"SL Misra","year":"2014","unstructured":"Misra SL, et al. Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus. J Diabetes Res. 2014. https:\/\/doi.org\/10.1155\/2014\/848659.","journal-title":"J Diabetes Res"},{"issue":"7","key":"1161_CR86","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/J.1755-3768.2010.01993.X","volume":"90","author":"TJ Wang","year":"2012","unstructured":"Wang TJ, Wang IJ, Hu CC, Lin HC. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7):663\u20138. https:\/\/doi.org\/10.1111\/J.1755-3768.2010.01993.X.","journal-title":"Acta Ophthalmol"},{"key":"1161_CR87","unstructured":"Moshirfar M, Benstead EE, Sorrentino PM, Tripathy K. Ocular neuropathic pain. StatPearls, 2023. [Online]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542282\/. Accessed 26 Mar 2025."},{"issue":"4","key":"1161_CR88","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1177\/11206721211060963\/ASSET\/IMAGES\/LARGE\/10.1177_11206721211060963-FIG10.JPEG","volume":"32","author":"A Basilious","year":"2022","unstructured":"Basilious A, Xu CY, Malvankar-Mehta MS. Dry eye disease and psychiatric disorders: a systematic review and meta-analysis. Eur J Ophthalmol. 2022;32(4):1872\u201389. https:\/\/doi.org\/10.1177\/11206721211060963\/ASSET\/IMAGES\/LARGE\/10.1177_11206721211060963-FIG10.JPEG.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"1161_CR89","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1177\/11206721231222063","volume":"34","author":"M Rolando","year":"2024","unstructured":"Rolando M, Arnaldi D, Minervino A, Aragona P, Barabino S. Dry eye in mind: Exploring the relationship between sleep and ocular surface diseases. Eur J Ophthalmol. 2024;34(4):1128\u201334. https:\/\/doi.org\/10.1177\/11206721231222063.","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"1161_CR90","doi-asserted-by":"publisher","DOI":"10.12890\/2024_004621","volume":"11","author":"A El-Ouakhoumi","year":"2024","unstructured":"El-Ouakhoumi A, Joulal H, Yousfi J, Benjilali L, Zahlane M, Essaadouni L. Refractory depressive disorder as the first manifestation of adolescent Sj\u00f6gren\u2019s syndrome, successfully treated with rituximab. Eur J Case Rep Intern Med. 2024;11(7): 004621. https:\/\/doi.org\/10.12890\/2024_004621.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"3","key":"1161_CR91","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/JCP.0000000000001382","volume":"41","author":"JJ Rakofsky","year":"2021","unstructured":"Rakofsky JJ, Rakofsky SI, Dunlop BW. Dry those crying eyes: the role of depression and antidepressants in dry eye disease. J Clin Psychopharmacol. 2021;41(3):295\u2013303. https:\/\/doi.org\/10.1097\/JCP.0000000000001382.","journal-title":"J Clin Psychopharmacol"},{"key":"1161_CR92","unstructured":"Pediatric Dry Eye\u2014American Academy of Ophthalmology. [Online]. https:\/\/www.aao.org\/education\/disease-review\/pediatric-dry-eye. Accessed 26 Mar 2025."},{"key":"1161_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.JTOS.2023.12.001","volume":"31","author":"F Stapleton","year":"2024","unstructured":"Stapleton F, Velez FG, Lau C, Wolffsohn JS. Dry eye disease in the young: a narrative review. Ocul Surf. 2024;31:11\u201320. https:\/\/doi.org\/10.1016\/J.JTOS.2023.12.001.","journal-title":"Ocul Surf"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01161-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:49:56Z","timestamp":1749872996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01161-8","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Antonio Pinna received honoraria from Thea Pharma Inc. and Bausch & Lomb for educational activity related to the topics of this manuscript. Andrea Leonardi is a consultant for Alcon, FAES Farma, FIDIA, Santen Pharmaceutical Co. Ltd., Laboratoires Th\u00e9a, SIFI, URSA-pharma. Pasquale Aragona, Stefano Barabino, Antonio Di Zazzo, Giuseppe Giannaccare, Edoardo Villani, Francesco Aiello, Elena Antoniazzi, Stefano Bonini, Emilia Cantera, Gianpaolo Carlini, Chiara Chierego, Rossella Colabelli, Romina Fasciani, Antonella Franch, Giovanna Gabbriellini, Caterina Maria Rita Gagliano, Angelo Macr\u00ec, Rita Mencucci, Luigi Mosca, Vincenzo Orfeo, Augusto Pocobelli, Romolo Protti, Paolo Rama, Laura Rania, Miguel Rechichi, Pierangela Rubino, Andrea Russo, Vincenzo Scorcia, Leopoldo Spadea, Marco Trentadue, Salvatore Troisi, Piera Versura, and Maurizio Rolando have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}